IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q1 2023 Holdings

Filed 2023-05-15 | 15 holdings | $39.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Savara Inc(SVRA)COM805111101$13.4M6,896,55134.0%
Xeris Biopharma Holdings Inc(XERS)COM98422E103$9.8M6,039,02824.9%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$6.5M15,94716.5%
Rezolute Inc(RZLT)COM NEW76200L309$2.7M1,403,1576.8%
Spdr SER TR(XOP)S&P OILGAS EXP78468R556$2.2M17,5005.6%
Vectivbio Hldg AGORD SHSH9060V101$1.3M156,6513.4%
Alps ETF TR(AMLP)ALERIAN MLP00162Q452$1.1M29,5002.9%
Molecular Templates IncCOM608550109$779.9K2,052,9912.0%
Compass Therapeutics Inc(CMPX)COM20454B104$675.5K211,7401.7%
Allakos Inc(ALLKGUSD)COM01671P100$385.1K86,5331.0%
Cabaletta BIO Inc(CABA)COM12674W109$335.6K40,5810.8%
Elevation Oncology IncCOM28623U101$129.8K68,3240.3%
Newamsterdam Pharma Company*W EXP 11/22/202N62509117$40.5K21,3330.1%
Bridgetown Holdings LTD*W EXP 09/30/202G1355U121$7.0K39,7730.0%
Lanvin Group Holdings Limite*W EXP 01/14/202G5380J118$4.5K12,0000.0%